ArticleHeliyon2024

Machine learning-driven mast cell gene signatures for prognostic and therapeutic prediction in prostate cancer.

Abudukeyoumu Maimaitiyiming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.